Citi initiated coverage of GE HealthCare with a Buy rating and $82 price target. GE Healthcare is a leading global provider of medical technologies and solutions, with over $18B in sales in 2022, bolstered by a vast installed base of 4M pieces of equipment across its segments, the analyst tells investors in a research note. The firm says the company’s “products are essential, and pervasive, throughout the healthcare continuum.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GEHC:
- GE HealthCare awarded $44M grant to develop AI ultrasound tech
- Mayo Clinic, GE HealthCare enter strategic healthcare collaboration
- GE HealthCare, Mass General Brigham announce AI algorithm collaboration
- GE HealthCare initiated with a Buy at Argus
- Hamilton collaboration transforms the future of medical imaging